← Back to Search

Human-AI Collaboration for Decision Making

N/A

Recruiting

Led By Jeremy M Wolfe, PhD

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to one week

Awards & highlights

Study Summary

This trial is testing how well humans do at making decisions when given different inputs from a simulated AI in a two-choice task.

Who is the study for?

This trial is open to everyone who can enroll online. However, participants must pass the Ishihara color vision test and have at least 20/25 vision with correction if needed.Check my eligibility

What is being tested?

The study tests how simulated AI as a Second Reader affects human decision-making in tasks like mammography screening when the frequency of cases (prevalence) changes.See study design

What are the potential side effects?

Since this trial involves decision-making tasks with computer-aided diagnosis tools rather than medical treatments, traditional physical side effects are not applicable.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to one week

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to one week

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to one week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Criterion

Secondary outcome measures

Reaction Time

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExperimentExperimental Treatment2 Interventions

All participants are tested in all conditions of this experiment.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,615 Previous Clinical Trials

11,470,815 Total Patients Enrolled

Jeremy M Wolfe, PhDPrincipal InvestigatorBrigham and Women's Hospital

3 Previous Clinical Trials

1,246 Total Patients Enrolled

Media Library

Simulated Second Reader AI Clinical Trial Eligibility Overview. Trial Name: NCT05272189 — N/A

Computer-Aided Diagnosis Research Study Groups: Experiment

Computer-Aided Diagnosis Clinical Trial 2023: Simulated Second Reader AI Highlights & Side Effects. Trial Name: NCT05272189 — N/A

Simulated Second Reader AI 2023 Treatment Timeline for Medical Study. Trial Name: NCT05272189 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the estimated participation rate of this clinical trial?

"Affirmative. Clinicaltrials.gov displays that this clinical trial, first launched on January 1st 2020, is still recruiting participants. 15 individuals are required for the study which has only one medical centre as a location."

Answered by AI

Are there any available openings to join this clinical experiment?

"Indeed, the details found on clinicaltrials.gov demonstrate that enrollment for this trial is ongoing. Originally created in January of 2020, it was updated as recently as February 28th 2022 and aims to recruit 15 individuals from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7

Jeremy M Wolfe, PhD 2020. "Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05272189.